Rapid Micro Biosystems, Inc. RPID
1.11
0.00
0.00%
as of 25 Sep
- Market cap
- $55.7M
- P/E
- 0.0×
Follow RPID
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(68.83%) | (86.82%) | (116.74%) | (141.65%) | |
| (46.56%) | (54.47%) | (67.84%) | (76.40%) | ||
ROIC |
(129.52%) | (214.45%) | (187.79%) | (181.64%) | |
Return on Tangible Assets |
(70.32%) | (91.23%) | (128.96%) | (141.15%) | |
Average Days of Receivables |
64.93 | 34.06 | 67.59 | 57.23 | |
Free Cash Flow per Share |
(0.86) | (0.71) | (0.84) | (0.84) | |
Free Cash Flow |
(38.58) | (31.91) | (37.98) | (40.39) | |
Capital Expenditures |
(0.86) | (0.85) | (0.92) | (0.34) | |
Piotroski F-Score |
3.00 | 3.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(36.13%) | (34.36%) | (59.38%) | (70.71%) | |
Accounts Receivable Turnover |
6.66 | 6.31 | 6.32 | 6.08 | |
Accounts Payable Turnover |
9.51 | 9.75 | 9.14 | 7.81 | |
Inventory Turnover |
1.33 | 1.72 | 1.75 | 1.68 | |
Average Days of Payables |
46.55 | 46.43 | 51.08 | 56.87 | |
Days of Inventory on Hand |
273.01 | 197.34 | 190.83 | 207.83 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
45.16% | 40.50% | 38.79% | 38.21% | |
Selling, General and Administrative Expense of Revenue |
111.33% | 103.72% | 108.36% | 108.79% | |
Share Based Compensation of Revenue |
13.42% | 12.01% | 12.26% | 12.27% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.85 | 0.66 | 0.74 | 0.78 | |
Depreciation/Fixed assets |
0.35 | 0.36 | 0.36 | 0.39 | |
Capex/Depreciation |
(0.26) | (0.26) | (0.29) | (0.11) | |
Revenue per Share |
0.68 | 0.75 | 0.76 | 0.73 | |
Operating CF per Share |
(0.84) | (0.70) | (0.82) | (0.83) | |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.01) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.01 | |
Net Profit Margin |
(145.11%) | (140.30%) | (145.81%) | (145.55%) |
Columns are period end dates